Nieuws

Schippers gaat innovatieve Nederlandse zorgbedrijvigheid (inter)nationaal stimuleren

6 oktober 2015 Minister Edith Schippers (VWS) gaat de ontwikkeling van Nederlandse medisch-technologische innovaties stimuleren. Er komen ‘Health Deals’ tussen overheid en (private) partners die duurzame zorginnovaties verder op weg helpen. Schippers wil met de sector Life Sciences & Health (LSH) op nieuwe economische missies gaan. De Tweede Kamer is vandaag over de plannen geïnformeerd.

Agendia Highlights Study Showing MammaPrint/BluePrint Tests Predict Response to Current Breast Cancer Chemotherapy and Targeted Therapy Regimens

6 oktober 2015 Agendia’s MammaPrint® and BluePrint® tests provide new insights that may provide many more women with beneficial treatment for breast cancer before surgery, according to findings presented at the 2015 Breast Cancer Symposium.

AM-Pharma and Pfizer Inc. shortlisted for "Best Partnership Alliance" in 2015 Scrip Awards

30 september 2015 AM‐Pharma B.V. and Pfizer Inc. have been nominated for the prestigious category of “Best Partnership Alliance” for the 11th Annual Scrip Awards, organised by Scrip Intelligence, the leading source of news and strategic analysis for the global pharmaceutical industry.

Cristal Therapeutics Starts Clinical Phase I Trial with Nanomedicine CriPec® Docetaxel in Patients with Solid Tumours

29 september 2015 Cristal Therapeutics, a privately-held life sciences company developing innovative drugs against cancer and other diseases, today announced the recent start of a clinical phase I trial with its lead candidate CriPec® docetaxel in patients with solid tumours.

Health~Holland launches online portal

29 september 2015 Under the flag of Health~Holland, the Top Sector Life Sciences & Health (LSH) aims to connect and support innovative organisations active in the Dutch LSH sector. This user-friendly online gateway serves as the central information hub for life sciences and health SMEs and other organisations in the Netherlands and internationally.

Aduro Biotech acquires BioNovion

28 september 2015 Aduro Biotech, Inc. and BioNovion Holding B.V. announced that they have entered into a definitive agreement for Aduro to acquire BioNovion, a privately held monoclonal antibody discovery and development company based in The Netherlands.

Kinesis Pharma and Venn Life Sciences will join forces

25 september 2015 Kinesis Pharma (Kinesis) and Venn Life Sciences (Venn) will join forces in offering drug development services to the pharmaceutical and biotech industry as well as to investors in these areas. The companies have entered into an agreement under which Venn will acquire the entire issued share capital of Kinesis.

Pan-European APPROACH project receives 15 million Euro research funding to find the right osteoarthritis medicine for the right patient

21 september 2015 In a bid to stimulate the development of much needed treatments for osteoarthritis, a consortium of 24 partners comprising pharmaceutical companies, biotech companies, academic institutions, not-for-profit organizations, small and medium enterprises (SMEs) and public bodies have joined forces in the pan-European APPROACH (Applied Public-Private Research enabling OsteoArthritis Clinical Headway) project, with total research funding of 15 million Euros.

Amgen to Aquire Privately-held Dezima Pharma

18 september 2015 Amgen (NASDAQ:AMGN) and Dezima Pharma B.V. (Dezima) announced that the companies have entered into a definitive acquisition agreement under which Amgen will acquire Dezima, a privately-held, Netherlands-based biotechnology company focused on developing innovative treatments for dyslipidemia. Dezima shareholders have approved the agreement.

Barend Mons appointed Chair of European Commission’s high level expert group on ‘European Open Science Cloud’

17 september 2015 Professor Barend Mons has been appointed Chair of the Commission High Level Expert Group "European Open Science Cloud", initiated by the European Commission, DG Research and Innovation.